Cargando…

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome

BACKGROUND: Differentiation syndrome (DS) is the main life-threatening adverse event that occurs in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA). Cytokine imbalances have been reported to play role during the developing of acute promyelocytic leukemia diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto de Almeida, Luciana, Pereira-Martins, Diego Antonio, Lima, Ana Sílvia Gouvêa, Baggio, Márcia Sueli, de Araujo Koury, Luisa Corrêa, Lange, Ana Paula, Bassi, Sarah Cristina, Scheucher, Priscila Santos, Rego, Eduardo Magalhães
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456372/ https://www.ncbi.nlm.nih.gov/pubmed/32859169 http://dx.doi.org/10.1186/s12885-020-07330-1

Ejemplares similares

Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
por: Bassi, Sarah Cristina, et al.
Publicado: (2012)

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
por: de Almeida, Luciana Yamamoto, et al.
Publicado: (2021)

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia
por: Thomé, Carolina Hassibe, et al.
Publicado: (2020)

Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study
por: Azevedo, Ilana de França, et al.
Publicado: (2017)

The results of the International Consortium on Acute Promyelocytic Leukemia: a 'proof of concept' of networking as a strategy to improve the outcome of treatment of hematological malignancies in developing countries
por: Rego, Eduardo Magalhães
Publicado: (2013)

Differentiation Syndrome in Promyelocytic Leukemia: Clinical Presentation, Pathogenesis and Treatment
por: Rego, E.M., et al.
Publicado: (2011)

MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
por: Pereira-Martins, Diego A., et al.
Publicado: (2021)

Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia
por: Weinhäuser, Isabel, et al.
Publicado: (2020)

Epidemiology and Treatment of Acute Promyelocytic Leukemia in Latin America
por: Rego, E.M., et al.
Publicado: (2011)

CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice
por: Lange, A.P., et al.
Publicado: (2019)

Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia
por: Furtado, Felipe Magalhães, et al.
Publicado: (2017)

Halofuginone Has Anti-Proliferative Effects in Acute Promyelocytic Leukemia by Modulating the Transforming Growth Factor Beta Signaling Pathway
por: de Figueiredo-Pontes, Lorena L., et al.
Publicado: (2011)

An Isolated Phlebolith on the Lip: An Unusual Case and Review of the Literature
por: Gouvêa Lima, Gabriela de Morais, et al.
Publicado: (2015)

Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia
por: Yoshinari, Gerson Hiroshi, et al.
Publicado: (2019)

Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression
por: Rego, Eduardo M., et al.
Publicado: (2001)

Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013
por: Pagnano, Katia Borgia Barbosa, et al.
Publicado: (2014)

Acute promyelocytic leukemia presenting as an extradural mass
por: Bittencourt, Henrique, et al.
Publicado: (2011)

Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model
por: Assis, Patricia A., et al.
Publicado: (2015)

Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia
por: Padovani, Karina Stringhetta, et al.
Publicado: (2021)

Treatment Outcome of Acute Promyelocytic Leukemia with Modified Aida Protocol
por: Pagnano, Kátia B. Barbosa, et al.
Publicado: (2010)

Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia
por: Gimenes-Teixeira, Hamilton L, et al.
Publicado: (2013)

ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype
por: Lucena-Araujo, Antonio R., et al.
Publicado: (2016)

Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells
Publicado: (1990)

Interleukin-24 enhancing antitumor activity of chimeric oncolytic adenovirus for treating acute promyelocytic leukemia cell
por: Liu, Li, et al.
Publicado: (2019)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations
por: da Silva, Fernanda Borges, et al.
Publicado: (2017)

Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
por: Machado-Neto, João Agostinho, et al.
Publicado: (2017)

Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012)

Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia
por: Sabljic, Nikica, et al.
Publicado: (2022)

NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2(V617F)-positive myeloproliferative neoplasm cells
por: Fenerich, Bruna Alves, et al.
Publicado: (2020)

History of Acute Promyelocytic Leukemia
por: Sanz, Miguel A., et al.
Publicado: (2021)

S308: RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN ACUTE PROMYELOCYTIC LEUKEMIA
por: Sabljic, Nikica, et al.
Publicado: (2023)

How to Promote Skin Repair? In-Depth Look at Pharmaceutical and Cosmetic Strategies
por: Torres, Ana, et al.
Publicado: (2023)

Interleukin-6 and interleukin-8 blood levels’ poor association with the severity and clinical profile of ex-smokers with COPD
por: de Moraes, Maria Rosedália, et al.
Publicado: (2014)

Follow-up and outcome of the twelve-year experience in adult patients with acute promyelocytic leukemia
por: Steffenello-Durigon, Giovanna, et al.
Publicado: (2021)

Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia
por: Albano, Francesco, et al.
Publicado: (2015)

Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020)

Papillon-Lefèvre syndrome
por: Silva, Thadeu Santos, et al.
Publicado: (2018)

Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms
por: Fernandes de Oliveira Costa, Amanda, et al.
Publicado: (2022)

Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia
por: De Angelis, Federico, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dc4hmerj0ch44krr4gjna7brmo